FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2139766730> ?p ?o ?g. }

• W2139766730 endingPage "29223" @default.
• W2139766730 startingPage "29209" @default.
• W2139766730 abstract "// Constance Vennin 1,2 , Nathalie Spruyt 3 , Fatima Dahmani 3 , Sylvain Julien 1,2 , François Bertucci 4 , Pascal Finetti 4 , Thierry Chassat 5 , Roland P. Bourette 3 , Xuefen Le Bourhis 1,2 and Eric Adriaenssens 1,2 1 INSERM U908, Cell Plasticity and Cancer, F-59655, Villeneuve d’Ascq, France 2 University of Lille, F-59655, Villeneuve d’Ascq, France 3 CNRS UMR 8161, F-59021, Lille, France 4 Paoli-Calmettes Institute, Aix -Marseille University, F-13009, Marseille, France 5 PLETHA, Institut Pasteur Lille, F-59019, Lille, France Correspondence to: Eric Adriaenssens, email: // Keywords : H19, miRNA, breast cancer, CBL, tyrosine kinase receptor Received : April 28, 2015 Accepted : July 16, 2015 Published : July 22, 2015 Abstract H19 is a long non-coding RNA precursor of miR-675microRNA. H19 is increasingly described to play key roles in the progression and metastasis of cancers from different tissue origins. We have previously shown that the H19 gene is activated by growth factors and increases breast cancer cell invasion. In this study, we established H19 /miR-675 ectopic expression models of MDA-MB-231 breast cancer cells to further investigate the underlying mechanisms of H19 oncogenic action. We showed that overexpression of H19 /miR-675 enhanced the aggressive phenotype of breast cancer cells including increased cell proliferation and migration in vitro , and increased tumor growth and metastasis in vivo . Moreover, we identified ubiquitin ligase E3 family (c-Cbl and Cbl-b) as direct targets of miR-675 in breast cancer cells. Using a luciferase assay, we demonstrated that H19 , through its microRNA, decreased both c-Cbl and Cbl-b expression in all breast cancer cell lines tested. Thus, by directly binding c-Cbl and Cbl-b mRNA, miR-675 increased the stability and the activation of EGFR and c-Met, leading to sustained activation of Akt and Erk as well as enhanced cell proliferation and migration. Our data describe a novel mechanism of protumoral action of H19 in breast cancer." @default.
• W2139766730 created "2016-06-24" @default.
• W2139766730 creator A5021763324 @default.
• W2139766730 creator A5021995972 @default.
• W2139766730 creator A5040081866 @default.
• W2139766730 creator A5051043754 @default.
• W2139766730 creator A5054254122 @default.
• W2139766730 creator A5062829559 @default.
• W2139766730 creator A5064613683 @default.
• W2139766730 creator A5079753614 @default.
• W2139766730 creator A5084660376 @default.
• W2139766730 creator A5091721810 @default.
• W2139766730 date "2015-07-22" @default.
• W2139766730 modified "2023-09-25" @default.
• W2139766730 title "<i>H19</i>non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b" @default.
• W2139766730 cites W1968482426 @default.
• W2139766730 cites W1974350437 @default.
• W2139766730 cites W1986694679 @default.
• W2139766730 cites W1989900133 @default.
• W2139766730 cites W1998317871 @default.
• W2139766730 cites W2000999796 @default.
• W2139766730 cites W2004714113 @default.
• W2139766730 cites W2028205153 @default.
• W2139766730 cites W2032555022 @default.
• W2139766730 cites W2045065079 @default.
• W2139766730 cites W2050159046 @default.
• W2139766730 cites W2052405541 @default.
• W2139766730 cites W2054191153 @default.
• W2139766730 cites W2059037016 @default.
• W2139766730 cites W2061881549 @default.
• W2139766730 cites W2064259001 @default.
• W2139766730 cites W2066081593 @default.
• W2139766730 cites W2071675221 @default.
• W2139766730 cites W2092823052 @default.
• W2139766730 cites W2096483233 @default.
• W2139766730 cites W2097398875 @default.
• W2139766730 cites W2101501894 @default.
• W2139766730 cites W2107959716 @default.
• W2139766730 cites W2110237047 @default.
• W2139766730 cites W2111047063 @default.
• W2139766730 cites W2122438978 @default.
• W2139766730 cites W2125995528 @default.
• W2139766730 cites W2130027655 @default.
• W2139766730 cites W2130753161 @default.
• W2139766730 cites W2140482407 @default.
• W2139766730 cites W2142857044 @default.
• W2139766730 cites W2147689539 @default.
• W2139766730 cites W2153454576 @default.
• W2139766730 cites W2157024381 @default.
• W2139766730 cites W2159762922 @default.
• W2139766730 cites W2171797570 @default.
• W2139766730 cites W2322245085 @default.
• W2139766730 cites W2334877760 @default.
• W2139766730 cites W2337962116 @default.
• W2139766730 doi "https://doi.org/10.18632/oncotarget.4976" @default.
• W2139766730 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4745721" @default.
• W2139766730 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26353930" @default.
• W2139766730 hasPublicationYear "2015" @default.
• W2139766730 type Work @default.
• W2139766730 sameAs 2139766730 @default.
• W2139766730 citedByCount "169" @default.
• W2139766730 countsByYear W21397667302015 @default.
• W2139766730 countsByYear W21397667302016 @default.
• W2139766730 countsByYear W21397667302017 @default.
• W2139766730 countsByYear W21397667302018 @default.
• W2139766730 countsByYear W21397667302019 @default.
• W2139766730 countsByYear W21397667302020 @default.
• W2139766730 countsByYear W21397667302021 @default.
• W2139766730 countsByYear W21397667302022 @default.
• W2139766730 countsByYear W21397667302023 @default.
• W2139766730 crossrefType "journal-article" @default.
• W2139766730 hasAuthorship W2139766730A5021763324 @default.
• W2139766730 hasAuthorship W2139766730A5021995972 @default.
• W2139766730 hasAuthorship W2139766730A5040081866 @default.
• W2139766730 hasAuthorship W2139766730A5051043754 @default.
• W2139766730 hasAuthorship W2139766730A5054254122 @default.
• W2139766730 hasAuthorship W2139766730A5062829559 @default.
• W2139766730 hasAuthorship W2139766730A5064613683 @default.
• W2139766730 hasAuthorship W2139766730A5079753614 @default.
• W2139766730 hasAuthorship W2139766730A5084660376 @default.
• W2139766730 hasAuthorship W2139766730A5091721810 @default.
• W2139766730 hasBestOaLocation W21397667301 @default.
• W2139766730 hasConcept C104317684 @default.
• W2139766730 hasConcept C121608353 @default.
• W2139766730 hasConcept C126322002 @default.
• W2139766730 hasConcept C145059251 @default.
• W2139766730 hasConcept C2779013556 @default.
• W2139766730 hasConcept C502942594 @default.
• W2139766730 hasConcept C530470458 @default.
• W2139766730 hasConcept C54355233 @default.
• W2139766730 hasConcept C555283112 @default.
• W2139766730 hasConcept C62112901 @default.
• W2139766730 hasConcept C71924100 @default.
• W2139766730 hasConcept C81885089 @default.
• W2139766730 hasConcept C86803240 @default.
• W2139766730 hasConcept C97037327 @default.
• W2139766730 hasConceptScore W2139766730C104317684 @default.
• W2139766730 hasConceptScore W2139766730C121608353 @default.

• next